2017 Weill Neurosciences Symposium

The inaugural UCSF Weill Institute for Neurosciences Symposium, held on May 25, 2017, brought together leaders in science and medicine, showcasing innovative research, inspiring ideas, and ways to pave new paths toward discovery.

The annual symposium will take on a different theme, offering a renewed focus on key issues and disease areas across the neurosciences. Featuring a truly exciting panel of speakers, this inaugural event focused on neurodegenerative diseases including Alzheimer's, Parkinson's, and ALS.

signage for the Weill Neurosciences Symposium 2017

a crowded auditorium at the Weill Neurosciences Symposium 2017


Download the symposium program [PDF]

Morning Session

Welcome & Opening Remarks
Stephen Hauser; Sandy and Joan Weill

Don W. Cleveland, PhD (University of California, San Diego)
Gene Silencing Therapy for Human Neurodegenerative Disease

M. Elizabeth Ross, MD, PhD (Weill Cornell Medicine)
Fetal Development Genes Repurposed in Brain Plasticity and Aging

Thomas C. Südhof, MD (Stanford University)
Synaptic and Non-Synaptic Signaling by ApoE: Implications for Alzheimer's Disease

Beth Stevens, PhD (Harvard University)
Immune Mechanisms of Synapse Loss in Health & Disease

Watch the morning session »

Afternoon Session

Kristine Yaffe, MD (University of California, San Francisco)
Neurodegeneration: A Population Health Perspective

Bruce L. Miller, MD (University of California, San Francisco)
The Landscape of Neurodegenerative Diseases

Lennart Mucke, MD (University of California, San Francisco)
Addressing the Multifactoriality of Neurodegenerative Diseases in Research and Therapeutic Development

Stanley B. Prusiner, MD (University of California, San Francisco)
Therapeutic Challenges and Opportunities

Roundtable Discussion

Watch the afternoon session »

Live Broadcast

Morning Session:

Afternoon Sessions: